Exogenous interleukin‐10 attenuates hyperoxia‐induced acute lung injury in mice

作者: Huai-Dong Li , Qing-Xiang Zhang , Zhi Mao , Xing-Jie Xu , Nai-Yi Li

DOI: 10.1113/EXPPHYSIOL.2014.083337

关键词: HyperoxiaBronchoalveolar lavageLung injuryLungMyeloperoxidaseEndocrinologyNecrosisMedicineNitric oxideImmunologyInternal medicineTumor necrosis factor alpha

摘要: New Findings What is the central question of this study? It not known whether treatment with interleukin-10 (IL-10) attenuates hyperoxia-induced acute lung injury in mice. What main finding and its importance? Our results showed that exogenous IL-10 alleviated mice, possibly by regulating neutrophil recruitment subsequent generation cytokines, nitric oxide matrix metalloproteinases. Lung caused breathing air enriched oxygen continues to be a major problem clinical medicine. Here, we investigated therapeutic role mice. In first experiment, mice were exposed room or 95% O2 treated simultaneously. second wild-type IL-10−/− O2. Exogenous attenuated injury, evidenced reduced ratio weight body weight, wet dry cell numbers protein content bronchoalveolar lavage fluid death. Interleukin-10 markedly prolonged survival during exposure. activity myeloperoxidase mRNA levels interleukin-6, tumour necrosis factor-α macrophage inflammatory protein 2, suppressed nuclear factor-κB activation decreased inducible synthnase expression formation lungs hyperoxia. activities metalloproteinase 2 metalloproteinase 9 permeability Furthermore, absence aggravated duration exposure, which was IL-10. conclusion, our show alleviates metalloproteinases. This suggests may promising strategy reduce patients

参考文章(40)
Anne-Karin Hesse, Martina Dörger, Christian Kupatt, Fritz Krombach, Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury Respiratory Research. ,vol. 5, pp. 11- 11 ,(2004) , 10.1186/1465-9921-5-11
Fei Chen, Vince Castranova, Xianglin Shi, Laurence M Demers, New Insights into the Role of Nuclear Factor-κB, a Ubiquitous Transcription Factor in the Initiation of Diseases Clinical Chemistry. ,vol. 45, pp. 7- 17 ,(1999) , 10.1093/CLINCHEM/45.1.7
Hiroyuki Yoshidome, Atsushi Kato, Michael J. Edwards, Alex B. Lentsch, Interleukin-10 inhibits pulmonary NF-κB activation and lung injury induced by hepatic ischemia-reperfusion American Journal of Physiology-lung Cellular and Molecular Physiology. ,vol. 277, ,(1999) , 10.1152/AJPLUNG.1999.277.5.L919
Donna M. Rennick, Madeline M. Fort, Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. American Journal of Physiology-gastrointestinal and Liver Physiology. ,vol. 278, ,(2000) , 10.1152/AJPGI.2000.278.6.G829
Lewis J Smith, None, Hyperoxic lung injury: biochemical, cellular, and morphologic characterization in the mouse. Journal of Laboratory and Clinical Medicine. ,vol. 106, pp. 269- 278 ,(1985)
R Tuder, R Shenkar, M Schwartz, E Abraham, L M Shea, C Beehler, Hyperoxia activates NF-kappaB and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. Journal of Immunology. ,vol. 157, pp. 3902- 3908 ,(1996)
Laura Dugo, Ivana Serraino, Emanuela Mazzon, Angela De Sarro, Achille P. Caputi, Tiziana Genovese, Rosanna Di Paola, Salvatore Cuzzocrea, Absence of endogenous interleukin-10 enhances the evolution of acute lung injury. European Cytokine Network. ,vol. 13, pp. 285- 297 ,(2002)
EDWARD D. CRANDALL, MICHAEL A. MATTHAY, Alveolar epithelial transport. Basic science to clinical medicine. American Journal of Respiratory and Critical Care Medicine. ,vol. 163, pp. 1021- 1029 ,(2001) , 10.1164/AJRCCM.163.4.2006116
Paul Bremner, Michael Heinrich, Natural products as targeted modulators of the nuclear factor-kappa B pathway Journal of Pharmacy and Pharmacology. ,vol. 54, pp. 453- 472 ,(2010) , 10.1211/0022357021778637